Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia.
Undervalued with reasonable growth potential.
Share Price & News
How has Georgia Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GHG's share price has been volatile over the past 3 months.
7 Day Return
GB Consumer Retailing
1 Year Return
GB Consumer Retailing
Return vs Industry: GHG underperformed the UK Consumer Retailing industry which returned -1% over the past year.
Return vs Market: GHG underperformed the UK Market which returned -9.5% over the past year.
Price Volatility Vs. Market
How volatile is Georgia Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StIf You Had Bought Georgia Healthcare Group (LON:GHG) Stock Three Years Ago, You'd Be Sitting On A 76% Loss, Today
2 months ago | Simply Wall StA Sliding Share Price Has Us Looking At Georgia Healthcare Group PLC's (LON:GHG) P/E Ratio
2 months ago | Simply Wall StGeorgia Healthcare Group PLC (LON:GHG) Earns A Nice Return On Capital Employed
Is Georgia Healthcare Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GHG (£0.83) is trading below our estimate of fair value (£9.08)
Significantly Below Fair Value: GHG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GHG is good value based on its PE Ratio (21.5x) compared to the Consumer Retailing industry average (22.7x).
PE vs Market: GHG is poor value based on its PE Ratio (21.5x) compared to the UK market (15x).
Price to Earnings Growth Ratio
PEG Ratio: GHG is good value based on its PEG Ratio (0.6x)
Price to Book Ratio
PB vs Industry: GHG is good value based on its PB Ratio (0.8x) compared to the GB Consumer Retailing industry average (1.2x).
How is Georgia Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GHG's forecast earnings growth (37.1% per year) is above the savings rate (1.2%).
Earnings vs Market: GHG's earnings (37.1% per year) are forecast to grow faster than the UK market (20.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GHG's revenue (7.1% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: GHG's revenue (7.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GHG's Return on Equity is forecast to be low in 3 years time (17.7%).
How has Georgia Healthcare Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GHG has high quality earnings.
Growing Profit Margin: GHG's current net profit margins (1.9%) are lower than last year (4%).
Past Earnings Growth Analysis
Earnings Trend: GHG's earnings have grown by 5.4% per year over the past 5 years.
Accelerating Growth: GHG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GHG had negative earnings growth (-45.4%) over the past year, making it difficult to compare to the Consumer Retailing industry average (-25.1%).
Return on Equity
High ROE: GHG's Return on Equity (6%) is considered low.
How is Georgia Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: GHG's short term assets (GEL445.4M) exceed its short term liabilities (GEL175.2M).
Long Term Liabilities: GHG's short term assets (GEL445.4M) do not cover its long term liabilities (GEL641.2M).
Debt to Equity History and Analysis
Debt Level: GHG's debt to equity ratio (64.2%) is considered high.
Reducing Debt: GHG's debt to equity ratio has reduced from 64.5% to 64.2% over the past 5 years.
Debt Coverage: GHG's debt is well covered by operating cash flow (43.4%).
Interest Coverage: GHG's interest payments on its debt are not well covered by EBIT (2.5x coverage).
What is Georgia Healthcare Group's current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GHG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GHG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GHG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GHG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: GHG is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GHG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Nick Gamkrelidze (39yo)
Mr. Nikoloz Gamkrelidze, also known as Nick, has been the Chief Executive Officer of Georgia Healthcare Group PLC since august 8, 2015. Mr. Gamkrelidze served as Group Chief Financial Officer and Deputy Ch ...
CEO Compensation Analysis
Compensation vs Market: Nick's total compensation ($USD1.68M) is above average for companies of similar size in the UK market ($USD341.60K).
Compensation vs Earnings: Nick's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|CEO & Executive Director||4.83yrs||GEL1.68m||0.29% GEL314.8k|
|Deputy CEO of Finance & Operations||3.25yrs||GEL371.49k||0.057% GEL62.5k|
|Head of Investor Relations||no data||no data||no data|
|Chief Legal Officer||5.17yrs||no data||no data|
|Head of Business Development & Strategic Marketing||no data||no data||0.53% GEL582.0k|
|Chief Human Resource Officer||5.17yrs||no data||no data|
|Deputy CEO of Risks & IT||3.25yrs||GEL370.97k||0.0083% GEL9.2k|
|Deputy Chief Executive Officer of Clinical||4.33yrs||no data||no data|
|Chief Operating Officer of Hospitals||5.25yrs||GEL376.46k||0.059% GEL65.2k|
|Head of Internal Audit||5.17yrs||no data||no data|
Experienced Management: GHG's management team is seasoned and experienced (5 years average tenure).
|CEO & Executive Director||4.83yrs||GEL1.68m||0.29% GEL314.8k|
|Independent Non-Executive Director||4.75yrs||GEL144.00k||0.011% GEL12.5k|
|Non-Executive Director||no data||no data||0.18% GEL196.8k|
|Independent Non-Executive Director||4.75yrs||GEL107.00k||no data|
|Senior Independent Non-Executive Director||4.75yrs||GEL156.00k||0.051% GEL55.7k|
|Independent Non-Executive Director||4.75yrs||GEL126.00k||no data|
|Independent Non-Executive Director||4.75yrs||GEL107.00k||0.0089% GEL9.8k|
|Independent Chairman of the Board||1.75yrs||GEL200.00k||0.082% GEL90.7k|
|Independent Non-Executive Director||1.75yrs||GEL100.00k||0.012% GEL12.8k|
Experienced Board: GHG's board of directors are considered experienced (4.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Georgia Healthcare Group PLC's company bio, employee growth, exchange listings and data sources
- Name: Georgia Healthcare Group PLC
- Ticker: GHG
- Exchange: LSE
- Founded: 2015
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: UK£110.050m
- Shares outstanding: 129.47m
- Website: https://www.ghg.com.ge
Number of Employees
- Georgia Healthcare Group PLC
- 84 Brook Street
- Greater London
- W1K 5EH
- United Kingdom
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|GHG||LSE (London Stock Exchange)||Yes||Common Shares||GB||GBP||Nov 2015|
|GHGL||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||GBP||Nov 2015|
|1EB||BST (Boerse-Stuttgart)||Yes||Common Shares||DE||EUR||Nov 2015|
|GHGA||LSE (London Stock Exchange)||ORD GBP0.01 (ASSD GEORGIA CAP)||GB||GBP||May 2020|
Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia. It operates through Healthcare Services, Pharmacy and Distribution, and Medical Insurance segments. The company operates 16 referral hospitals with a total of 2,825 beds that offer secondary and tertiary level healthcare services; 21 community hospitals, including 495 beds providing basic outpatient and inpatient healthcare services; and 270 pharmacies under the GPC and Pharmadepot brand names. It also operates 16 polyclinics, day-clinics, and 8 dental clinics that offer outpatient diagnostic and treatment services; provides a range of medical insurance products, such as personal accident, term life, and medical and travel insurance policies to corporate and retail clients; and medicines, as well as Para pharmacy products. The company was founded in 2015 and is headquartered in London, the United Kingdom. Georgia Healthcare Group PLC operates as a subsidiary of Georgia Capital PLC.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/06 00:23|
|End of Day Share Price||2020/06/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.